36 related articles for article (PubMed ID: 17336213)
1. Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.
Levin N; Killingberg KT; Halvorsen TO; Danielsen S; Grønberg BH
Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38583494
[TBL] [Abstract][Full Text] [Related]
2. Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study.
Banla LI; Tzeng A; Baillieul JP; Kandekhar MJ; Fitzgerald KJ; LoPiccolo J; Poitras HA; Soto DE; Rotow JK; Singer L; Willers H; Kozono DE; Janne PA; Mak RH; Piotrowska Z; Keane FK; Kann BH
JTO Clin Res Rep; 2023 Oct; 4(10):100559. PubMed ID: 37732171
[TBL] [Abstract][Full Text] [Related]
3. Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update.
Pollock AE; Shinn L; Anderson R; Butler S; Pollock J
Lung Cancer (Auckl); 2018; 9():79-84. PubMed ID: 30237747
[TBL] [Abstract][Full Text] [Related]
4. The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591).
Atherton PJ; Watkins-Bruner DW; Gotay C; Moinpour CM; Satele DV; Winter KA; Schaefer PL; Movsas B; Sloan JA
J Pain Symptom Manage; 2015 Oct; 50(4):470-9.e9. PubMed ID: 26031708
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of tomotherapy-based image-guided radiotherapy for small cell lung cancer.
Nguyen NP; Shen W; Kratz S; Vock J; Vos P; Vincent VH; Altdorfer G; Ewell L; Jang S; Karlsson U; Godinez J; Mills M; Sroka T; Dutta S; Chi A;
Front Oncol; 2013; 3():289. PubMed ID: 24324932
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients.
Gibson RJ; Keefe DM; Lalla RV; Bateman E; Blijlevens N; Fijlstra M; King EE; Stringer AM; van der Velden WJ; Yazbeck R; Elad S; Bowen JM;
Support Care Cancer; 2013 Jan; 21(1):313-26. PubMed ID: 23142924
[TBL] [Abstract][Full Text] [Related]
7. Comparative proteomic and radiobiological analyses in human lung adenocarcinoma cells.
Wei R; Zhang Y; Shen L; Jiang W; Li C; Zhong M; Xie Y; Yang D; He L; Zhou Q
Mol Cell Biochem; 2012 Jan; 359(1-2):151-9. PubMed ID: 21822689
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
Foster NR; Mandrekar SJ; Schild SE; Nelson GD; Rowland KM; Deming RL; Kozelsky TF; Marks RS; Jett JR; Adjei AA
Cancer; 2009 Jun; 115(12):2721-31. PubMed ID: 19402175
[TBL] [Abstract][Full Text] [Related]
9. Combined modality therapy for limited-disease small cell lung cancer.
Raez L; Samuels M; Lilenbaum R
Curr Treat Options Oncol; 2005 Jan; 6(1):69-74. PubMed ID: 15610716
[TBL] [Abstract][Full Text] [Related]
10. Limited stage small cell lung cancer.
Murray N; Sheehan F
Curr Treat Options Oncol; 2001 Feb; 2(1):63-70. PubMed ID: 12057141
[TBL] [Abstract][Full Text] [Related]
11. Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer.
Garces YI; Okuno SH; Schild SE; Mandrekar SJ; Bot BM; Martens JM; Wender DB; Soori GS; Moore DF; Kozelsky TF; Jett JR
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):995-1001. PubMed ID: 17336213
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer.
Lu C; Komaki R; Lee JS; Shin DM; Palmer JL; Coldman BJ; Pisters KM; Kurie JM; Fossella FV; Glisson BS
Clin Cancer Res; 2003 Jun; 9(6):2085-91. PubMed ID: 12796372
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903.
Kubota K; Nishiwaki Y; Sugiura T; Noda K; Mori K; Kawahara M; Negoro S; Watanabe K; Imamura F; Tamura T; Saijo N
Clin Cancer Res; 2005 Aug; 11(15):5534-8. PubMed ID: 16061870
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
Lung Cancer; 2006 Jul; 53(1):59-65. PubMed ID: 16716447
[TBL] [Abstract][Full Text] [Related]
15. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
